<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document SYSTEM "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP1064301A1" country="EP" dtd-version="ep-patent-document-v1-4.dtd" doc-number="1064301" date-publ="20010103" file="99910541.4" lang="en" kind="A1" status="n"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI....CY..</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>DIM360   - Ver 2.9 (30 Jun 1998) 1100000/0 1710000/0</B007EP></eptags></B000><B100><B110>1064301</B110><B130>A1</B130><B140><date>20010103</date></B140><B190>EP</B190></B100><B200><B210>99910541.4</B210><B220><date>19990318</date></B220><B240><B241><date>20000905</date></B241></B240><B250>En</B250><B251EP>En</B251EP><B260>En</B260></B200><B300><B310>9805792</B310><B320><date>19980318</date></B320><B330><ctry>GB</ctry></B330></B300><B400><B405><date>20010103</date><bnum>200101</bnum></B405><B430><date>20010103</date><bnum>200101</bnum></B430></B400><B500><B510><B516>7</B516><B511> 7C 07K  14/00   A</B511></B510><B540><B541>de</B541><B542>MITGLIEDER DER YAEL FAMILIE AUS BAKTERIEN ZUR HERSTELLUNG VON ANTIMIKROBIELLEN ARZNEIMITTELN</B542><B541>en</B541><B542>BACTERIAL YAEL FAMILY MEMBERS AS TARGETS FOR ANTIMICROBIAL DRUG DESIGN</B542><B541>fr</B541><B542>FAMILLE DE POLYPEPTIDES BACTERIENS</B542></B540></B500><B700><B710><B711><snm>GLAXO GROUP LIMITED</snm><iid>00203920</iid><irf>PS3401/EPw</irf><adr><str>Glaxo Wellcome HouseBerkeley Avenue</str><city>Greenford, Middlesex UB6 ONN</city><ctry>GB</ctry></adr></B711></B710><B720><B721><snm>ARIGONI, Fabrizio</snm><adr><str>2, rue Maurice</str><city>CH-1204 Geneva</city><ctry>CH</ctry></adr></B721><B721><snm>EDGERTON, Michael David</snm><adr><str>Dekalb Genetics</str><city>62 Maritime Drive,Mystic, CT 06355</city><ctry>US</ctry></adr></B721><B721><snm>LOFERER, Hannes</snm><adr><str>Alpenstrasse 74</str><city>D-82538 Geretsried</city><ctry>DE</ctry></adr></B721><B721><snm>PEITSCH, Manuel, C.</snm><adr><str>En Jaquerod</str><city>CH-1855 La Forclaz</city><ctry>CH</ctry></adr></B721></B720><B740><B741><snm>Rees, Marion Lindsay</snm><iid>00077391</iid><adr><str>Glaxo Wellcome plc,Glaxo Wellcome House,Intellectual Property Department,Berkeley Avenue</str><city>Greenford,Middlesex UB6 0NN</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B860><B861><dnum><anum>GB9900850</anum></dnum><date>19990318</date></B861><B862>En</B862></B860><B870><B871><dnum><pnum>WO9947553</pnum></dnum><date>19990923</date><bnum>199938</bnum></B871></B870></B800></SDOBI></ep-patent-document>
